(3S)-1-[(3-chloro-2-methylbenzene)sulfonyl]- N-cyclohexylpiperidine-3-carboxamide
![(3S)-1-[(3-chloro-2-methylbenzene)sulfonyl]-
N-cyclohexylpiperidine-3-carboxamide price.](/CAS/20180808/GIF/872506-67-7.gif)
|
- $503.65 - $1067.85
- Product name: (3S)-1-[(3-chloro-2-methylbenzene)sulfonyl]- N-cyclohexylpiperidine-3-carboxamide
- CAS: 872506-67-7
- MF: C19H27ClN2O3S
- MW: 398.95
- EINECS:
- MDL Number:MFCD11226407
- Synonyms:(3S)-1-[(3-chloro-2-methylbenzene)sulfonyl]- N-cyclohexylpiperidine-3-carboxamide;11β-HSD1-IN-12;3-Piperidinecarboxamide, 1-[(3-chloro-2-methylphenyl)sulfonyl]-N-cyclohexyl-, (3S)-;(S)-1-((3-Chloro-2-methylphenyl)sulfonyl)-N-cyclohexylpiperidine-3-carboxamide
2 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
Package
- 5MG
- 1G
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberKIN0000438
- Product descriptionINCB-13739 95.00%
- Packaging5MG
- Price$503.65
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberKIN0000438
- Product descriptionINCB-13739 95.00%
- Packaging1G
- Price$1067.85
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | KIN0000438 | INCB-13739 95.00% | 5MG | $503.65 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | KIN0000438 | INCB-13739 95.00% | 1G | $1067.85 | 2021-12-16 | Buy |
Properties
Density :1.29±0.1 g/cm3(Predicted)
pka :15.29±0.20(Predicted)
pka :15.29±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
Description
INCB13739 is a potent, selective, oral 11βHSD1 inhibitor (IC50=1.1 nM) for the treatment of type 2 diabetes. INCB-13739 has high selectivity for 11beta-HSD1 over other dehydrogenases and glucocorticoid and mineralocorticoid receptors, with prolonged pharmacodynamic activity and good pharmacokinetic/pharmacodynamic properties. INCB-13739 demonstrated improved hepatic and peripheral insulin sensitivity with a satisfactory reduction in fasting plasma glucose and cholesterolSuppliers and manufacturers
Blocksynth Pharmaceutical Technology Co.,Ltd
LEAPCHEM CO., LTD.
Tianjin Kailiqi Biotechnology Co., Ltd.
DC Chemicals
Nanjing Shizhou Biology Technology Co.,Ltd
Nanjing Shizhou Biology Technology Co.,Ltd
Jinan Jiuli Biotechnology Co. , Ltd.
Bide Pharmatech Ltd.
Ningbo Zhenyue Pharmaceutical Technology Co., Ltd
TargetMol Chemicals Inc.